High resolution analysis of functional determinants on human tissue-type plasminogen activator
- PMID: 1900516
High resolution analysis of functional determinants on human tissue-type plasminogen activator
Abstract
Sixty-four variants of human tissue-type plasminogen activator (tPA) were produced using recombinant DNA techniques. Charged residues were converted to alanine in clusters of from one to four changes per variant; these clusters spanned all the domains of the molecule. The variants were expressed by mammalian cells and were analyzed for a variety of properties. Variants of tPA were found that had reduced activity with respect to each tested property; in a few cases increased activity was observed. Analysis of these effects prompted the following conclusions: 1) charged residues in the nonprotease domains are less involved in fibrin stimulation of tPA activity than those in the protease domain, and it is possible to increase the fibrin specificity (i.e. the stimulation of tPA activity by fibrin compared to fibrinogen) by mutations at several sites in the protease domain; 2) the difference in enzymatic activity between the one- and two-chain forms of tPA can be increased by mutations at several sites on the protease domain; 3) binding of tPA to lysine-Sepharose was affected only by mutations to kringle-2, whereas binding to fibrin was affected most by mutations in the other domains; 4) clot lysis was influenced by mutations in all domains except kringle-2; 5) sensitivity to plasminogen activator inhibitor-1 seems to reside exclusively in the region surrounding residue 300. A model of the tPA protease domain has been used to map some of the critical residues and regions.
Similar articles
-
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295. Protein Eng. 1995. PMID: 8869642
-
Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.Blood. 1993 Mar 1;81(5):1312-22. Blood. 1993. PMID: 8382971
-
Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.Eur J Biochem. 1993 Apr 1;213(1):437-43. doi: 10.1111/j.1432-1033.1993.tb17779.x. Eur J Biochem. 1993. PMID: 8386628
-
Hybrid molecules: insights into plasminogen activator function.Mol Biol Med. 1991 Apr;8(2):245-55. Mol Biol Med. 1991. PMID: 1806766 Review.
-
Molecular mechanisms of initiation of fibrinolysis by fibrin.Thromb Haemost. 2003 Mar;89(3):409-19. Thromb Haemost. 2003. PMID: 12624622 Review.
Cited by
-
Tenecteplase Thrombolysis for Acute Ischemic Stroke.Stroke. 2020 Nov;51(11):3440-3451. doi: 10.1161/STROKEAHA.120.029749. Epub 2020 Oct 13. Stroke. 2020. PMID: 33045929 Free PMC article. Review.
-
Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):375-86. Biochem J. 1999. PMID: 10024513 Free PMC article.
-
Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.J Biol Chem. 2015 Oct 23;290(43):25795-804. doi: 10.1074/jbc.M115.677567. Epub 2015 Aug 31. J Biol Chem. 2015. PMID: 26324706 Free PMC article.
-
An intramolecular t-SNARE complex functions in vivo without the syntaxin NH2-terminal regulatory domain.J Cell Biol. 2006 Jan 16;172(2):295-307. doi: 10.1083/jcb.200507138. Epub 2006 Jan 9. J Cell Biol. 2006. PMID: 16401725 Free PMC article.
-
Actin structure and function: roles in mitochondrial organization and morphogenesis in budding yeast and identification of the phalloidin-binding site.Mol Biol Cell. 1993 Dec;4(12):1277-94. doi: 10.1091/mbc.4.12.1277. Mol Biol Cell. 1993. PMID: 8167410 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources